Susquehanna International Group, LLP Cure Vac N.V. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Cure Vac N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 85,324 shares of CVAC stock, worth $252,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,324

Previous 150,633 43.36%

Holding current value

$252,559

Previous $512,000 51.17%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.74 - $3.79 $178,946 - $247,521	-65,309 Reduced 43.36%	85,324 $250,000
Q2 2024 Aug 15, 2024	BUY	$2.31 - $4.99 $56,193 - $121,386	24,326 Added 19.26%	150,633 $512,000
Q1 2024 May 07, 2024	SELL	$2.94 - $4.34 $152,483 - $225,094	-51,865 Reduced 29.11%	126,307 $382,000
Q4 2023 Feb 14, 2024	SELL	$3.96 - $6.41 $178,995 - $289,738	-45,201 Reduced 20.24%	178,172 $750,000
Q3 2023 Nov 14, 2023	SELL	$6.5 - $10.77 $1.02 Million - $1.7 Million	-157,626 Reduced 41.37%	223,373 $1.53 Million
Q2 2023 Aug 11, 2023	BUY	$6.69 - $12.25 $1.74 Million - $3.18 Million	259,910 Added 214.64%	380,999 $3.97 Million
Q1 2023 May 16, 2023	BUY	$6.38 - $12.5 $772,547 - $1.51 Million	121,089 New	121,089 $843,000
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $526,188 - $1.07 Million	-70,346 Reduced 40.12%	105,001 $827,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $1.47 Million - $2.16 Million	-111,322 Reduced 38.83%	175,347 $2.39 Million
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $495,458 - $1.19 Million	33,636 Added 13.29%	286,669 $5.62 Million
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $591,077 - $845,248	17,529 Added 7.44%	253,033 $8.68 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $6.67 Million - $10.1 Million	135,405 Added 135.27%	235,504 $12.9 Million
Q2 2021 Aug 11, 2021	SELL	$56.91 - $127.53 $12.3 Million - $27.5 Million	-215,939 Reduced 68.33%	100,099 $7.36 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $15.5 Million - $24.5 Million	194,291 Added 159.59%	316,038 $28.9 Million
Q4 2020 Feb 16, 2021	SELL	$46.76 - $136.27 $177,173 - $516,327	-3,789 Reduced 3.02%	121,747 $9.87 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $77.2 $5.5 Million - $9.69 Million	125,536 New	125,536 $5.84 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.3M

Call Options Held

164K

Put Options Held

117K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $555M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cure Vac N.V. Transaction History